Retinal diseases: RNA therapeutics show promise but is India ready?
Discover the importance of vision, genetic eye disorders, and RNA-based therapies for precision treatment in India and ...
4DMT Announces Corporate Webcast to Review Interim 52-week Results from the Phase 2b Cohort of PRISM in a Broad Wet AMD Population
Initial interim 52-week results from Phase 2b Population Extension cohort of PRISM clinical trial to be presented by Dante Pieramici, M.D., a ...